A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.
Also called NCT01672762
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT01672762
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01672762. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05-25 (actual); primary completion 2013-04-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- ipragliflozin
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01672762- Content hash
56105001df0aa9f28b9523d5757bd923ffc68ea89b92f8318f89d8e99371a715